Robinson Pharma Inc., (RPI) has completed a $1 million dollar expansion, rebuild and refit of its in-house analytical laboratories. The improvements included significant investments in state-of-the-art analytical equipment and the addition of several full-time positions to the quality and analytical teams. RPI’s expanded business volume and the requirements of daily operations under the new dietary supplement GMPs have increased internal demand for identity, purity and potency testing of ingredients and finished products. This investment allows RPI to process a wider array of ingredients more rapidly. The new infrastructure also decreases the wait time from completion of production to release for shipment, according to the company. For further information: www.robinsonpharma.com